Annette Juul Vangsted

Annette Juul Vangsted

Clinical Associate Professor

Member of:

  • Internal Medicine: Haematology


Publication year:
All
1 - 25 out of 59Page size: 25
  1. 2023
  2. Published

    A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk

    Dicanio, M., Giaccherini, M., Clay-Gilmour, A., Macauda, A., Sainz, J., Machiela, M. J., Rybicka-Ramos, M., Norman, A. D., Tyczyńska, A., Chanock, S. J., Barington, T., Kumar, S. K., Bhatti, P., Cozen, W., Brown, E. E., Suska, A., Haastrup, E. K., Orlowski, R. Z., Dudziński, M., Garcia-Sanz, R. & 42 others, Kruszewski, M., Martinez-Lopez, J., Beider, K., Iskierka-Jazdzewska, E., Pelosini, M., Berndt, S. I., Raźny, M., Jamroziak, K., Rajkumar, S. V., Jurczyszyn, A., Vangsted, Annette Juul, Collado, P. G., Vogel, U., Hofmann, J. N., Petrini, M., Butrym, A., Slager, S. L., Ziv, E., Subocz, E., Giles, G. G., Andersen, N. F., Mazur, G., Watek, M., Lesueur, F., Hildebrandt, M. A. T., Zawirska, D., Ebbesen, L. H., Marques, H., Gemignani, F., Dumontet, C., Várkonyi, J., Buda, G., Nagler, A., Druzd-Sitek, A., Wu, X., Kadar, K., Camp, N. J., Grzasko, N., Waller, R. G., Vachon, C., Canzian, F. & Campa, D., 2023, In: International Journal of Cancer. 152, 2, p. 239-248 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Geographical and ecological analyses of multiple myeloma in Denmark: Identification of potential hotspot areas and impact of urbanisation

    Bertelsen, L. D., Børty Nielsen, L., Christensen, H. S., Bøgsted, M., Gregersen, H., Pedersen, R. S., Klostergaard, A., Schnack, B. I., Pedersen, P. T., Abildgaard, N., Hermansen, E., Vangsted, Annette Juul & Severinsen, M. T., 2023, In: European Journal of Haematology. 110, 3, p. 289-295 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Improved survival in myeloma patients– a nationwide registry study of 4647 patients ≥75 years treated in Denmark and Sweden

    Moore, K. L. F., Turesson, I., Genell, A., Klausen, T. W., Knut-bojanowska, D., Redder, L., Sverrisdottir, I., Thorsen, J., Vangsted, Annette Juul, Blimark, C. H. & Nordic Myeloma Study Group, N. M. S. G., 2023, In: Haematologica. 108, 6, p. 1640-1651 43 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Lenalidomide Maintenance in Multiple Myeloma: A Retrospective, Nationwide, Real-World Study

    Harsløf, Mads, Chanchiri, I., Silkjær, T., Frølund, U. C., Teodorescu, E. M., Nielsen, K. B., Nielsen, P. I., Pedersen, P. T., Iversen, K. F., Grønbæk, Kirsten, Vangsted, Annette Juul, Thorsteinsdottir, S. & Szabo, A. G., 2023, In: Blood. 142, Supplement 1, p. 1979 1 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)

    Terpos, E., Musto, P., Engelhardt, M., Delforge, M., Cook, G., Gay, F., van de Donk, N. W. C. J., Ntanasis-Stathopoulos, I., Vangsted, A. J., Driessen, C., Schjesvold, F., Cerchione, C., Zweegman, S., Hajek, R., Moreau, P., Einsele, H., San-Miguel, J., Boccadoro, M., Dimopoulos, M. A., Sonneveld, P. & 1 others, Ludwig, H., 2023, In: Leukemia. 37, 6, p. 1175-1185 11 p.

    Research output: Contribution to journal › Review › Research › peer-review

  7. Published

    Phase I Study of Safety and Pharmacokinetics of RO7297089, an Anti-BCMA/CD16a Bispecific Antibody, in Patients with Relapsed, Refractory Multiple Myeloma

    Plesner, T., Harrison, S. J., Quach, H., Lee, C., Bryant, A., Vangsted, Annette Juul, Estell, J., Delforge, M., Offner, F., Twomey, P., Choeurng, V., Li, J., Hendricks, R., Ruppert, S. M., Sumiyoshi, T., Miller, K., Cho, E. & Schjesvold, F., 2023, In: Clinical Hematology International. 5, 1, p. 43-51 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization

    Clavero, E., Sanchez-Maldonado, J. M., Macauda, A., Ter Horst, R., Sampaio-Marques, B., Jurczyszyn, A., Clay-Gilmour, A., Stein, A., Hildebrandt, M. A. T., Weinhold, N., Buda, G., García-Sanz, R., Tomczak, W., Vogel, U., Jerez, A., Zawirska, D., Wątek, M., Hofmann, J. N., Landi, S., Spinelli, J. J. & 52 others, Butrym, A., Kumar, A., Martínez-López, J., Galimberti, S., Sarasquete, M. E., Subocz, E., Iskierka-Jażdżewska, E., Giles, G. G., Rybicka-Ramos, M., Kruszewski, M., Abildgaard, N., Verdejo, F. G., Sánchez Rovira, P., da Silva Filho, M. I., Kadar, K., Razny, M., Cozen, W., Pelosini, M., Jurado, M., Bhatti, P., Dudzinski, M., Druzd-Sitek, A., Orciuolo, E., Li, Y., Norman, A. D., Zaucha, J. M., Reis, R. M., Markiewicz, M., Rodríguez Sevilla, J. J., Andersen, V., Jamroziak, K., Hemminki, K., Berndt, S. I., Rajkumar, V., Mazur, G., Kumar, S. K., Ludovico, P., Nagler, A., Chanock, S. J., Dumontet, C., Machiela, M. J., Varkonyi, J., Camp, N. J., Ziv, E., Vangsted, Annette Juul, Brown, E. E., Campa, D., Vachon, C. M., Netea, M. G., Canzian, F., Försti, A. & Sainz, J., 2023, In: International Journal of Molecular Sciences. 24, 10, 20 p., 8500.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Potential value of pre-planned imaging of bone disease in multiple myeloma

    Nordic Myeloma Study Group, N. M. S. G., 2023, In: Blood Cancer Journal. 13, 1, 5 p., 105.

    Research output: Contribution to journal › Editorial › Research › peer-review

  10. 2022
  11. Published

    A polygenic risk score for multiple myeloma risk prediction

    Canzian, F., Piredda, C., Macauda, A., Zawirska, D., Andersen, N. F., Nagler, A., Zaucha, J. M., Mazur, G., Dumontet, C., Wątek, M., Jamroziak, K., Sainz, J., Várkonyi, J., Butrym, A., Beider, K., Abildgaard, N., Lesueur, F., Dudziński, M., Vangsted, A. J., Pelosini, M. & 20 others, Subocz, E., Petrini, M., Buda, G., Raźny, M., Gemignani, F., Marques, H., Orciuolo, E., Kadar, K., Jurczyszyn, A., Druzd-Sitek, A., Vogel, U., Andersen, V., Reis, R. M., Suska, A., Avet-Loiseau, H., Kruszewski, M., Tomczak, W., Rymko, M., Minvielle, S. & Campa, D., 2022, In: European Journal of Human Genetics. 30, 4, p. 474-479 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group

    Gregersen, H., Peceliunas, V., Remes, K., Schjesvold, F., Abildgaard, N., Nahi, H., Andersen, N. F., Vangsted, A. J., Klausen, T. W., Helleberg, C., Carlson, K., Frølund, U. C., Axelsson, P., Stromberg, O., Blimark, C. H., Crafoord, J., Tsykunova, G., Eshoj, H. R., Waage, A., Hansson, M. & 1 others, Gulbrandsen, N., 2022, In: European Journal of Haematology. 108, 1, p. 34-44 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?

    MacAuda, A., Clay-Gilmour, A., Hielscher, T., Hildebrandt, M. A. T., Kruszewski, M., Orlowski, R. Z., Kumar, S. K., Ziv, E., Orciuolo, E., Brown, E. E., Försti, A., Waller, R. G., MacHiela, M. J., Chanock, S. J., Camp, N. J., Rymko, M., Raźny, M., Cozen, W., Várkonyi, J., Piredda, C. & 36 others, Pelosini, M., Belachew, A. A., Subocz, E., Hemminki, K., Rybicka-Ramos, M., Giles, G. G., Milne, R. L., Hofmann, J. N., Zaucha, J. M. I., Vangsted, Annette Juul, Goldschmidt, H., Rajkumar, S. V., Tomczak, W., Sainz, J., Butrym, A., Watek, M., Iskierka-Jazdzewska, E., Buda, G., Robinson, D. P., Jurczyszyn, A., Dudzinski, M., Martinez-Lopez, J., Sinnwell, J. P., Slager, S. L., Jamroziak, K., Reis, R. M. V., Weinhold, N., Bhatti, P., Carvajal-Carmona, L. G., Zawirska, D., Norman, A. D., Mazur, G., Berndt, S. I., Campa, D., Vachon, C. M. & Canzian, F., 2022, In: Cancer Epidemiology Biomarkers and Prevention. 31, 9, p. 1863-1866

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. Published

    Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries

    Blimark, C. H., Vangsted, Annette Juul, Klausen, T. W., Gregersen, H., Szabo, A. G., Hermansen, E., Wålinder, G., Knut-Bojanowska, D., Zang, C., Turesson, I. & the Real-World Evidence Group within the Nordic Myeloma Study Group (NMSG), T. R. E. G. W. T. N. M. S. G. (., 2022, In: European Journal of Haematology. 108, 2, p. 99-108 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  15. Published

    The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy

    Szabo, A. G., Thorsen, J., Iversen, K. F., Levring, M. B., Preiss, B., Helleberg, C., Breinholt, M. F., Hermansen, E., Gjerdrum, Lise Mette Rahbek, Bønløkke, S. T., Nielsen, K., Kjeldsen, E., Teodorescu, E. M., Dokhi, M., Kurt, E., Strandholdt, C. N., Andersen, M. K. & Vangsted, Annette Juul, 2022, In: American Journal of Hematology. 97, 3, p. E117-E120

    Research output: Contribution to journal › Letter › Research › peer-review

  16. Published

    The role of E3 ubiquitin ligase in multiple myeloma: potential for cereblon E3 ligase modulators in the treatment of relapsed/refractory disease

    Richardson, P. G., Mateos, M. V., Vangsted, Annette Juul, Ramasamy, K., Abildgaard, N., Ho, P. J., Quach, H. & Bahlis, N. J., 2022, In: Expert Review of Proteomics. 19, 4-6, p. 235-246

    Research output: Contribution to journal › Review › Research › peer-review

  17. 2021
  18. Published

    Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival

    Melaiu, O., Macauda, A., Sainz, J., Calvetti, D., Facioni, M. S., Maccari, G., ter Horst, R., Netea, M. G., Li, Y., Grząśko, N., Moreno, V., Jurczyszyn, A., Jerez, A., Watek, M., Varkonyi, J., Garcia-Sanz, R., Kruszewski, M., Dudziński, M., Kadar, K., Jacobsen, S. E. H. & 34 others, Mazur, G., Andersen, V., Rybicka, M., Zawirska, D., Raźny, M., Zaucha, J. M., Ostrovsky, O., Iskierka-Jazdzewska, E., Reis, R. M., Stępień, A., Beider, K., Nagler, A., Druzd-Sitek, A., Marques, H., Martìnez-Lopez, J., Lesueur, F., Avet-Loiseau, H., Vangsted, Annette Juul, Krawczyk-Kulis, M., Butrym, A., Jamroziak, K., Dumontet, C., Vogel, U., Rymko, M., Pelosini, M., Subocz, E., Szombath, G., Sarasquete, M. E., Silvestri, R., Morani, F., Landi, S., Campa, D., Canzian, F. & Gemignani, F., 15 Apr 2021, In: International Journal of Cancer. 148, 8, p. 1887-1894 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  19. Published

    2021 European myeloma network review and consensus statement on smoldering multiple myeloma: How to distinguish (and manage) Dr. Jekyll and Mr. Hyde

    Musto, P., Engelhardt, M., Caers, J., Bolli, N., Kaiser, M., van de Donk, N., Terpos, E., Broijl, A., de Larrea, C. F., Gay, F., Goldschmidt, H., Hajek, R., Vangsted, A. J., Zamagni, E., Zweegman, S., Cavo, M., Dimopoulos, M., Einsele, H., Ludwig, H., Barosi, G. & 4 others, Boccadoro, M., Mateos, M. V., Sonneveld, P. & Miguel, J. S., 2021, In: Haematologica. 106, 11, p. 2799-2812

    Research output: Contribution to journal › Review › Research › peer-review

  20. Published

    Incidence and clinical characteristics of multiple myeloma with low M-protein levels and normal values of hemoglobin, creatinine, calcium, and serum free light chain ratio

    Szabo, A. G., Klausen, T. W., Abildgaard, N., Gregersen, H., Silkjær, T., Pedersen, P. T., Pedersen, R. S., Helleberg, C., Hermansen, E., Schnack, B. I. & Vangsted, Annette Juul, 2021, In: Blood Cancer Journal. 11, 4, 70.

    Research output: Contribution to journal › Letter › Research › peer-review

  21. Published

    Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients

    Højholt, K. L., Gregersen, H., Szabo, A. G., Klausen, T. W., Levring, M. B., Preiss, B., Helleberg, C., Breinholt, M. F., Hermansen, E., Gjerdrum, Lise Mette Rahbek, Bønløkke, S. T., Nielsen, K., Kjeldsen, E., Iversen, K. F., Teodorescu, E. M., Kurt, E., Strandholdt, C., Andersen, M. K. & Vangsted, Annette Juul, 2021, In: Hematological Oncology. 39, 4, p. 521-528

    Research output: Contribution to journal › Journal article › Research › peer-review

  22. Published

    Phase I Study of Venetoclax Plus Daratumumab and Dexamethasone, With or Without Bortezomib, in Patients With Relapsed or Refractory Multiple Myeloma With and Without t(11;14)

    Bahlis, N. J., Baz, R., Harrison, S. J., Quach, H., Ho, S. J., Vangsted, Annette Juul, Plesner, T., Moreau, P., Gibbs, S. D., Coppola, S., Yang, X., Al Masud, A., Ross, J. A., Bueno, O. & Kaufman, J. L., 2021, In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39, 32, p. 3602-3612

    Research output: Contribution to journal › Journal article › Research › peer-review

  23. Published

    The real-world outcomes of multiple myeloma patients treated with daratumumab

    Szabo, A. G., Klausen, T. W., Levring, M. B., Preiss, B., Helleberg, C., Breinholt, M. F., Hermansen, E., Gjerdrum, Lise Mette Rahbek, Bønløkke, S. T., Nielsen, K., Kjeldsen, E., Iversen, K. F., Teodorescu, E. M., Dokhi, M., Kurt, E., Strandholdt, C., Andersen, M. K. & Vangsted, Annette Juul, 2021, In: Plos One. 16, 10 October, p. 1-11 e0258487.

    Research output: Contribution to journal › Journal article › Research › peer-review

  24. Published

    Validation of the UK myeloma research alliance risk profile, a new clinical prediction model for outcome in patients with newly diagnosed multiple myeloma not eligible for autologous stem cell transplantation; a population-based study from the Danish national multiple myeloma registry

    Redder, L., Klausen, T. W., Vangsted, Annette Juul, Gregersen, H., Andersen, N. F., Pedersen, R. S., Szabo, A. G., Frederiksen, M., Frølund, U. C., Helleberg, C., Nielsen, L. K., Pedersen, P. T., Salomo, M., Gimsing, P., Frederiksen, H. & Abildgaard, N., 2021, In: British Journal of Haematology. 193, 1, p. 119-124 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  25. 2020
  26. Published

    Clinically-suspected cast nephropathy: A retrospective, national, real-world study

    Szabo, A. G., Thorsen, Jonathan Jan Ilve, Iversen, K. F., Hansen, C. T., Teodorescu, E. M., Pedersen, S. B., Flaeng, S. B., Strandholdt, C., Frederiksen, M., Vase, M. Ø., Frølund, U. C., Krustrup, D., Plesner, T. & Vangsted, Annette Juul, 2020, In: American Journal of Hematology. 95, 11, p. 1352-1360 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  27. Published

    Human P2X7 Receptor Causes Cycle Arrest in RPMI-8226 Myeloma Cells to Alter the Interaction with Osteoblasts and Osteoclasts

    Agrawal, A., Kruse, L. S., Vangsted, Annette Juul, Gartland, A. & Jørgensen, Niklas Rye, 2020, In: Cells. 9, 11

    Research output: Contribution to journal › Journal article › Research › peer-review

  28. Published

    Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)

    Terpos, E., Engelhardt, M., Cook, G., Gay, F., Mateos, M. V., Ntanasis-Stathopoulos, I., van de Donk, N. W. C. J., Avet-Loiseau, H., Hajek, R., Vangsted, Annette Juul, Ludwig, H., Zweegman, S., Moreau, P., Einsele, H., Boccadoro, M., San Miguel, J., Dimopoulos, M. A. & Sonneveld, P., 2020, In: Leukemia. 34, 8, p. 2000-2011 12 p.

    Research output: Contribution to journal › Review › Research › peer-review

  29. 2019
  30. Published

    Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study

    Campa, D., Martino, A., Macauda, A., Dudziński, M., Suska, A., Druzd-Sitek, A., Raab, M-S., Moreno, V., Huhn, S., Butrym, A., Sainz, J., Szombath, G., Rymko, M., Marques, H., Lesueur, F., Vangsted, A. J., Vogel, U., Kruszewski, M., Subocz, E., Buda, G. & 27 others, Iskierka-Jażdżewska, E., Ríos, R., Merz, M., Schöttker, B., Mazur, G., Perrial, E., Martinez-Lopez, J., Butterbach, K., García Sanz, R., Goldschmidt, H., Brenner, H., Jamroziak, K., Reis, R. M., Kadar, K., Dumontet, C., Wątek, M., Haastrup, E. K., Helbig, G., Jurczyszyn, A., Jerez, A., Varkonyi, J., Barington, T., Grzasko, N., Zaucha, J. M., Andersen, V., Zawirska, D. & Canzian, F., Jul 2019, In: Leukemia and Lymphoma. 60, 7, p. 1803-1811 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 Next

ID: 9762536